Mary Ann E. Moore - 16 Nov 2021 Form 3 Insider Report for MEDNAX, INC. (MD)

Role
EVP Chief ERM/Legal Ops Off
Signature
/s/ Dominic J. Andreano, Attorney-in-Fact
Issuer symbol
MD
Transactions as of
16 Nov 2021
Net transactions value
$0
Form type
3
Filing time
23 Nov 2021, 16:00:26 UTC
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MD Common Stock 16,880 16 Nov 2021 By Trust F1
holding MD Common Stock 14,221 16 Nov 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein.
F2 2. Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan in connection with annual equity awards. 5,631 shares vest on March 1, 2022, 4,508 shares vest on March 1, 2023 and 4,082 shares vest on March 1, 2024.

Remarks:

Exhibit 24 - Power of Attorney